ST2-ANTIGENBINDENDE PROTEINE

Patent europeic · EP2850103 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2850103
Numer da la dumonda
EP13790269
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
17-05-2013
Publitgà
25-03-2015
Concedì
22-07-2020
La protecziun finescha il pli tard
16-05-2033
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
C07K 16/28 (2006.01)
Prioritad
US 201261649147 P 18.05.2012
US 201361792619 P 15.03.2013
Dumonda PCT
PCT/US2013/041656 17.05.2013
Publicaziun PCT
WO2013/173761 21.11.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-06-2026

    Midada

    Published in Swissreg on 01.06.2026

  2. 01-06-2025

    Midada

    Published in Swissreg on 01.06.2025

  3. 02-06-2024

    Midada

    Published in Swissreg on 02.06.2024

  4. 01-06-2023

    Midada

    Published in Swissreg on 01.06.2023

  5. 22-07-2020

    Concedì

    Published in Swissreg on 22.07.2020

Partidas

Possessur

Amgen Inc.

One Amgen Center Drive, Thousand Oaks, California 91320-1799, US

Inventur

COMEAU, Michael R.

Bainbridge Island, Washington 98110, US

LIM, Ai Ching

Mercer Island, Washington 98040, US

SHI, Donghui

Thousand Oaks, California 91362, US

WANG, Zhulun

Palo Alto, California 94306, US

FOLTZ, Ian

Burnaby, BC V5A 4B9, CA

SMITH, Dirk E.

Bainbridge Island, Washington 98110, US

MIN, Xiaoshan

Burlingame, California 94010, US

KETCHEM, Randal R.

Snohomish, Washington 98296, US

KING, Chadwick T.

North Vancouver, BC V7L 3T5, CA

CLARK, Rutilio

Bainbridge Island, Washington 98110, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.